Table 2.
Group | 10 Gy | 14 Gy | 18 Gy | 22 Gy |
---|---|---|---|---|
Irradiation dosea (Gy) | 9.9 ± 0.4 | 14.0 ± 0.1 | 18.0 ± 0.7 | 22.0 ± 0.2 |
ILSb | 188 ± 99 | 336 ± 127 | 420 ± 112 | 413 ± 192 |
T/Cc | ||||
Day 2 | 22 ± 22 | 17 ± 30 | 28 ± 26 | 21 ± 14 |
Day 6 | 50 ± 13 | 48 ± 23 | 58 ± 12 | 48 ± 13 |
Day 8 | 47 ± 17 | 50 ± 21 | 61 ± 16 | 50 ± 17 |
Day 10 | 50 ± 11 | 57 ± 30 | 68 ± 20 | 56 ± 19 |
Day 13 | 70 ± 32 | 71 ± 15 | 75 ± 14 | 70 ± 9 |
Day 15 | 77 ± 10 | 82 ± 17 | 88 ± 7 | 82 ± 8 |
Day 17 | 77 ± 8 | 77 ± 28 | 89 ± 4 | 84 ± 8 |
Day 20 | 81 ± 22 | 81 ± 19 | 94 ± 4 | 91 ± 4 |
aDose in gray (Gy, mean ± SD)
bIncreased life span in percentage to control (mean ± SD)
cTumor-to-control tumor volume ratio (T/C) in percentage to control (mean ± SD)